$诺华制药(NVS)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001370368-22-000012  Act: 34  Size: 43 KB 网页链接